Displaying 1 - 2 of 2 for Cancer - Neuroblastoma
  • GINAKIT2 - Treatment for Neuroblastoma (H-41033)
    • The purpose of this study is to find the largest effective and safe dose of GD2-CAR NKT cells to evaluate their effect on the tumor and how long they can be detected in the patient's blood and what affect they have on the patient's neuroblastoma.
  • ICare: Improving Care for Cancer Survivors (H-43629)
    • This study addresses the need to clarify system, provider and survivor-level facilitators of survivorship care plans implementation/use to guide future rollout efforts.